however, the genetic factors influencing treatment response remain largely unexplored
This is a delicate chemical structure, and being aggressive can damage it
As a consumer representative, I worry what placing a bulk substance on the list conveys in terms of FDA approval, said committee member Todd Durham, senior vice president of clinical outcomes and research at the Foundation Fighting Blindness, who voted no on adding these peptides to the list
The supplemental approval was granted based on data from the Phase III EMBARK trial, which studied Xtandi plus leuprolide, placebo plus leuprolide (a synthetic hormone regulator) and Xtandi as a monotherapy
Since many people on GLP-1 medications also manage cholesterol with statins, the double depletion can produce significant fatigue and muscle weakness